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• Studies on the impact of hospitalization as a trigger factor for VTE are limited. 
• We explored this association in a case-crossover study of cancer-free VTE patients. 
• Hospitalization without concurrent immobilization was a major trigger for VTE. 






Background: Previous studies have reported that around 50% of patients with venous 
thromboembolism (VTE) has undergone recent hospitalization. However, studies on the impact of 
hospitalization as a trigger factor for VTE are limited. 
Objectives: To investigate the impact of hospitalization with and without concurrent immobilization 
as a trigger factor for VTE. 
Methods: We conducted a case-crossover study of 530 cancer-free VTE patients. Hospitalizations 
were registered during the 90-day period preceding the VTE diagnosis (hazard period), and in four 
preceding 90-day control periods. A 90-day washout period between the control- and hazard periods 
was implemented to avoid potential carry-over effects. Conditional logistic regression was used to 
calculate odds ratios (OR) of VTE according to hospitalization. 
Results: In total, 159 (30%) of the VTE-patients had been hospitalized in the hazard period, and the 
OR of hospitalization was 9.4 (95% CI: 6.8-12.8). The risk increased slightly with the total number of 
days spent in hospital (OR per day: 1.11, 95% CI: 1.04-1.18), and with the number of hospitalizations 
(OR 8.9, 95% CI: 6.4-12.4 for 1 hospitalization and OR 12.3, 95% CI 6.4-23.6 for ≥2 hospitalizations). 
Hospitalization without immobilization was 6-times (OR: 6.3, 95% CI: 4.4-9.2) more common, 
whereas hospitalization with immobilization was near 20-times (OR: 19.8, 95% CI: 11.5-34.0) more 
common in the 90-days prior to a VTE compared to the control periods. 
Conclusions: Hospitalization is a major trigger factor for VTE also in the absence of immobilization. 
However, immobilization contributes substantially to the risk of VTE among hospitalized patients.  
 





Venous thromboembolism (VTE), a conceptual term for deep vein thrombosis (DVT) and pulmonary 
embolism (PE), is a common disease with severe complications [1-5]. Population based studies have 
indicated that around 40-60% of the VTE cases can be attributed to current or recent hospitalization 
or nursing home residency [5, 6]. Case-control studies have reported a 7 to 21-fold increased risk of 
VTE following recent hospitalization [7, 8]. Moreover, a longitudinal study from Olmsted County (US), 
reported that the risk of experiencing a first or recurrent VTE was 35-fold increased during the 92 
days following a hospitalization [9]. Although hospitalization is acknowledged as a risk factor for VTE, 
the role of hospitalization as a trigger factor for VTE has not been extensively studied.  
Hospitalization is often accompanied by immobilization. Immobilization is associated with a 2 
to 11-fold increased risk of VTE among hospitalized patients [10, 11], and up to 25% of medical 
patients developing a hospital-related VTE has been shown to be immobilized preceding the event 
[12, 13].  Thus, the increased risk of VTE observed in hospitalized patients may be partly explained by 
immobilization. Most previous studies have not been able to disentangle this relationship due to lack 
of information on immobilization, and some studies have even used hospitalization as a proxy for 
immobilization [14]. The influence of immobilization on the risk of hospital-related VTE, and to what 
extent hospitalization without concurrent immobilization serves as a trigger of VTE, have not been 
well addressed.  
In the present study, we set out to investigate the impact of hospitalization as a trigger of 
VTE, and to explore the influence of immobilization on this relationship in a population-based case-
crossover study of VTE patients. We also investigated the influence of hospital-related factors, such 
as length of hospital-stay and frequency of hospital admissions, on the risk of VTE. Our hypothesis 
was that hospitalization is a major trigger for VTE also in the absence of immobilization, and that the 







Study population and outcome assessment 
The source population comprised of subjects participating in the fourth survey of the Tromsø study, a 
single-center, population based, prospective cohort study, with repeated health surveys of the 
inhabitants in the municipality of Tromsø, Norway. The fourth survey was conducted in 1994/95, and 
included 27 158 inhabitants above 24 years. Further details about the Tromsø study can be found 
elsewhere [15]. All participants gave an informed written consent, and the study was approved by 
The Regional Committee of Medical and Health Research Ethics.  Participants were followed from the 
inclusion date (1994/95) through December 31, 2012, and all first-lifetime symptomatic, objectively 
confirmed VTE events (n= 707) during the course of follow-up were recorded by thorough 
identification and validation as previously described [16]. These 707 patients formed the basis of our 
case-crossover study.  
Study design 
In the case-crossover design, each case serves as his or her own control (self-matching), thereby 
controlling for risk factors that are constant within an individual (e.g. inherited thrombophilia), but 
vary between study objects. We defined the 90-day period prior to the VTE as the hazard period, and 
4 consecutive 90-day periods preceding the hazard period as control periods (C1-C4). A 90-day wash-
out period was implemented between the risk and control periods, to avoid potential carry-over 
effects (Figure 1). This allows for comparison of exposure-frequency in the hazard period to control 
periods, and makes the design especially suited to study the effect of transient exposures (e.g. 
hospitalization) on acute events (e.g. VTE). Patients with cancer in the hazard period were excluded 
(n=177), as cancer progression may change an individual’s VTE risk even over a short time-period, 
and thereby potentially introduce confounding. Consequently, 530 cancer-free VTE patients were 





Trained personnel reviewed the medical records for each VTE case, and systematically collected 
information on potential trigger factors for each of the 90-day periods using standardized forms. 
Moreover, diagnostic procedures, surgical and medical treatment, laboratory tests and diagnosis 
during hospital admissions, day-case and outpatient clinic visits in any of the control or hazard 
periods were recorded. Exposures extending over several days, were registered and considered to 
have occurred if any of the days of exposure fell within the specified 90-day period.  
Hospitalization was defined as being admitted to the hospital for more than 48 hours in the 
control or hazard periods. Hospital admissions >80 days were not registered as hospitalizations, as 
these were likely to be admitted to rehabilitation wards. The date of hospital admission and hospital 
discharge was used to estimate the length of hospital stay for each hospital contact. Re-admissions 
during each 90-day period were registered individually, and the total number of hospitalizations and 
total number of days spent in hospital was calculated for each 90-day period. Hospitalizations were 
categorized according to the main diagnosis assigned by the treating physician(s) using the 9th and 
10th revisions of the International Classification of Diseases and Related Health Problems (ICD-9 and 
ICD-10). Each hospital admission was assessed individually, and patients could therefore contribute 
with multiple hospitalizations within each case or control period. Patients were classified in 7 broad 
categories, i.e. infection, chronic obstructive pulmonary disease (COPD), heart failure, acute coronary 
syndrome (ACS), neurologic disease, surgery (i.e. both major or minor, or admission to any surgical 
ward) or trauma, and others.  
Immobilization was defined as the presence of one or more of the following; confinement to 
bed ≥3 days, ECOG score of four, or other immobilizing factors specified in the patient’s medical 
record (e.g. transient or persistent use of wheelchair, cast immobilization, etc.). CRP was analyzed in 
serum with a particle-enhanced immunoturbidimetric assay at the Department of Clincal Chemistry.  
Statistical analysis 
All statistical analysis were performed using STATA version 14.0 (Stata Corporation LP, College 




logistic regression was used to calculate odds ratios (ORs) with 95% confidence intervals (CI) for 
hospitalization in the hazard and control periods, as well as for the influence of duration of hospital 
stay and number of hospital admissions on the risk of VTE. Duration of hospital stay was analyzed as 
a continuous variable, and the OR was expressed per 1-day increase in hospital stay. To separate the 
effect of total days in hospital from frequency of admissions on the VTE risk, we performed a 
separate analysis adjusting the number of hospital admissions for the length of hospital stay. In order 
to address the impact of hospitalization as a trigger in the absence of immobilization, we performed 
an analysis with exposure categorized as not hospitalized, hospitalized without immobilization and 
hospitalized with immobilization. Since surgery is recognized as a strong trigger for VTE, we 
performed a separate analysis restricted to patients who did not have surgery.  
Hospitalization with immobilization could possibly reflect a more severe underlying condition 
and a worse health condition in general. To test this hypothesis, we estimated the mean maximum 
CRP-level (mg/L) during hospitalization in patients with and without immobilization, as a proxy for 
the inflammatory state. Furthermore, to examine the potential role of confounding by occult cancer, 




Characteristics of the 530 VTE patients are given in Table 1. The mean age was 68 years, 54.1% were 
women and 17.7% were obese. There were 296 (55.8%) DVTs and 228 (43.0%) PEs with or without 
concurrent DVT. Among the VTE’s, 84.0% (445) were community acquired, 10.6% (56) acquired their 
VTE in-hospital, and 5.4% (29) were nursing home residents. An overview of the categorization of 
hospital admissions according to the main diagnosis assigned by the treating physician in the hazard 
and control periods is provided in table 2. There were no substantial differences in the reason for 
hospitalization in the hazard compared to the control periods, except that hospitalization with heart 




The OR according to hospitalization, length of hospital stay and number of hospitalizations, in 
hazard and control periods are shown in Table 2. Overall, 30.0% (n=159) of the patients had been 
hospitalized at least once in the hazard period (n=530), compared to 6.2% (n=132) in the control 
periods (n=2120). The hospital admissions were evenly distributed among the four control periods, 
with 5.9% (n=31) occurring in C1, 5.5% (n=29) in C2, 6.4% (n=34) in C3 and 7.2% (n=38) in C4, 
respectively. Multiple hospitalizations were more common in the hazard period than in the control 
periods (5.5% vs. 1.6%), and patients were generally hospitalized for a longer time in the hazard 
period than in the control periods (median of 11 days, IQR: 6-18 vs. median of 6 days, IQR: 3-12). The 
OR for hospitalization as a trigger of VTE was 9.4 (95% CI: 6.8-12.8) (Table 2). The OR increased 
according to the number of hospitalizations within each period from 8.9 (95% CI: 6.4-12.4) in those 
with one hospitalization to 12.3 (95% CI 6.4-23.6) in those with ≥2 hospitalizations. After adjusting 
the number of hospitalization for the total number of days spent in hospital, there was no significant 
difference in the VTE risk between those with one compared to patients with two or more 
hospitalizations (OR: 1.8, 95% CI: 0.6-5.2). Overall, there was an 11% increased odds per one day 
increase in the total number of days spent in hospital (OR: 1.11, 95% CI: 1.04-1.18), and the OR for 
hospitalization ≥5 days was 5.2 (95% CI: 1.8-15.1), compared to patients hospitalized for 1-4 days 
(Table 2). These results remained unchanged after adjustment for the frequency of hospital 
admissions (data not shown). 
The ORs according to hospitalization with and without immobilization are shown in Table 3. 
Overall, 74 (46.5%) of the 159 patients hospitalized in the hazard period were considered to be 
immobilized, compared to 34 (25.8%) of the 132 patients hospitalized in the control periods. 
Hospitalization without immobilization was 6-times (OR: 6.3, 95% CI: 4.4-9.2) more common, 
whereas hospitalization with immobilization was near 20-times (OR: 19.8, 95% CI: 11.5-34.0) more 
common in the 90-days prior to a VTE compared to the control periods. The results were essentially 




with an OR of 5.0 (95% CI: 3.2-7.9) and 14.4 (95% CI: 7.4-27.9) for hospitalization without and with 
immobilization, respectively (Table 3). 
Immobilization during the hospital stay could reflect a more severe underlying condition, and 
therefore we recorded the maximum CRP levels measured during the hospital stay for each patient. 
The mean maximum CRP-level was 109 ± 96 mg/L in hospitalized patients who were immobilized and 
82 ± 89 mg/L in hospitalized patients who were not immobilized. Sensitivity analysis excluding 
patients who developed cancer in the following year (n=18) after VTE produced essentially similar 
results (data not shown). 
 
Discussion  
In the present case-crossover study, we found that hospitalization was a major trigger associated 
with a 9-fold higher risk of VTE. The triggering effect of hospitalization was mainly dependent on the 
length of hospital stay, but not the frequency of hospital admissions. The risk of VTE increased with 
11% per one day increase in total days spent in hospital during the 90-day hazard period, and the risk 
was 5-fold in those with hospital admissions for ≥5 days compared to those with shorter hospital 
stays (i.e. 1-4 days). Furthermore, we found that hospitalization without immobilization was over 6-
times more common, and that hospitalization with immobilization was near 20-times more common, 
in the 90-day period preceding a VTE compared to the control periods. The results were comparable 
when the analyses were restricted to patients who did not undergo surgery. Our results indicate that 
hospitalization is a major trigger factor for incident VTE also in the absence of immobilization. 
Moreover, our findings confirm that concomitant immobility increases the risk of VTE among 
hospitalized patients.  
Several studies have investigated hospitalization as a risk factor for VTE. In a nested case-
control study of 625 patients with a first lifetime VTE and 625 patients without VTE, hospital or 
nursing home confinement (institutionalization) was an independent risk factor for VTE, with an OR 




surgery, the odds of VTE was almost 22-fold and 8-fold increased, respectively, compared to patients 
with neither institutionalization nor recent surgery. In the AT-AGE study, a case-control study of 
elderly individuals, hospitalization was associated with an almost 15-fold increased risk of VTE within 
the first 2 weeks after hospital-discharge [8]. The risk was similar in surgery- and non-surgery-related 
hospitalizations (OR: 6.6 and 5.5, respectively), when compared to individuals without 
hospitalization. Furthermore, in a recent cohort study with hospitalization as a time-varying 
covariate, the risk of VTE was 35-fold increased in the period up to 92 days following a hospitalization 
[9].  
Case-crossover studies are suitable to study triggers of acute diseases, since they are 
designed to answer the question “why did this disease occur right now?”. This is in contrast to case-
control and cohort studies which compare the risk between individuals, and thereby are designed to 
answer the question “why me?”.  Although previous studies have addressed hospitalization as a risk 
factor for VTE, few studies have investigated the role of hospitalization as a trigger of VTE using a 
case-crossover design. In one previous case-crossover study, any non-surgical hospitalization or 
skilled nursing home facility stay was found to be a significant trigger associated with a 4.2-fold 
higher risk of VTE [14]. Interestingly, adjustment for other hospital-related factors like major surgery, 
infection, blood transfusion, use of central venous catheters, injuries and medication, did not 
markedly influence the risk estimates, even though many of these factors most likely are in the 
causal pathway.  
Few observational studies have evaluated the influence of length of hospitalization and 
frequency of hospital admissions on the risk of VTE. In a case-control study of older adults (≥60 years) 
[17], Yousuf et al found that hospitalization for 4-6 days and for ≥7 days was associated with a 2.4- 
and 3.4-fold increased risk of VTE compared to patients who were hospitalized for 0-3 days. In a 
matched case-control study of outpatients with a VTE diagnosis during the 90-days following hospital 
discharge [18], increasing number of hospitalizations and increasing length of hospital stay was both 




admission and increased by 17% for each additional day spent in the hospital. In the present study, 
we found that the risk of VTE increased with 11% per one day increase in total days spent in hospital 
during the 90-day hazard period, and the risk was 5-times higher in those with hospital admissions ≥5 
days compared to 1-4 days. Conversely, we did not find any substantial differences in the VTE-risk in 
those with multiple hospitalizations compared to those with a single hospitalization prior to their 
VTE. Furthermore, after conditioning on the length of hospital stay there was no differences in the 
risk of VTE in those with one compared to ≥2 hospitalizations, placing further emphasis on 
hospitalization as a high risk situation that is mainly dependent on the length of hospital stay rather 
than the frequency of admissions.  
Immobilization is a strong trigger of VTE which often concurs with hospitalization. Few 
studies have been able to disentangle the effect of immobilization from that of hospitalization, and 
hospitalization has frequently been used as a proxy for immobilization when studying the risk of VTE, 
as high-quality data on immobilization is often lacking. A previous meta-analysis on immobilization 
and VTE-risk among hospitalized inpatients reported a relative risk of 1.5 across 7 cohort studies and 
an OR of 2.5 across 3 case-control studies [10]. In our study, hospitalization with immobilization was 
3-times more common prior to a VTE than hospitalization without immobilization, supporting that 
immobilization contributes substantially to the risk of VTE among hospitalized patients. In agreement 
with our findings, two previous case-control studies on elderly patients, reported that immobility 
mediated the risk of VTE in a dose-response related manner, depending on both the type and 
duration of immobility [19], and that the risk was highest among patients who were bedridden in 
hospital [8, 19]. Our study showed that hospitalization without immobilization was 6-times more 
common prior to a VTE compared to equivalent control periods. This highlights that hospitalization is 
a high-risk situation even in the absence of immobilization, and that thromboprophylaxis should be 
considered also among non-immobilized patients. The VTE risk associated with hospitalization is 
dependent on the reason for hospitalization (e.g. surgery, cancer, infections or acute medical 




genetic risk profile) [20-23]. Moreover, the risk can be directly related to the number of risk factors 
present [20, 22, 24], as thrombosis develops once the accumulation of risk factors in an individual is 
sufficient to exceed the thrombosis threshold [25]. Appropriate risk stratification among hospitalized 
patients is therefore challenging, and further research is needed to develop risk stratification models 
that can accurately identify subjects at high risk of hospital-related VTE.  
In addition to being a risk factor in itself, immobilization may reflect a more severe 
underlying disease and a generally worse health condition. Accordingly, we found a higher mean 
CRP-level in hospitalized patients who were immobilized compared to hospitalized patients who 
were not immobilized, indicating that there could be a difference in disease severity among these 
patients. Consequently, there could also be differences in the use of thromboprohylaxis in patients 
with and without restricted mobility, as immobilized patients with severe conditions are more likely 
to receive anticoagulant treatment. In the present study, 36.1% of the patients who were 
hospitalized without being immobilized, and 50.9% of those who were hospitalized with 
immobilization prior to their VTE received thromboprophylaxis, suggesting that our risk estimates 
may have been underestimated. Our data strongly indicates confounding by indication for 
thromboprophylaxis. Consequently, we could not adjust our analysis for thromboprophylaxis as this 
would introduce bias.  
There are several strengths of the present study. The case-crossover design is especially 
suited to study triggers of disease, as information on different exposures are collected for several 
pre-defined time periods, allowing for comparison of exposure and exposure frequencies across 
different time periods in relation to the disease. Furthermore, since each subject serves as its own 
control, potential confounders such as chronic diseases and conditions are controlled for by the 
design. The present study included a large sample size of VTE patients recruited from a general 
population, which strengthens the external validity of our results. Moreover, the case-crossover 
design may partly adjust for the heterogeneity of the hospitalized population, as each subject serves 




during the hospital stay. A limitation of the case-crossover design is that it is susceptible to 
confounding by factors that change over time within individuals. However, this can be minimized by 
fitting the control periods as close to the hazard periods as possible. Moreover, all information in this 
study was collected retrospectively using hospital records, and the data therefore relies on thorough 
registration by the treating physicians and other health care professionals. Consequently, any other 
factors not accounted for in the medical records could potentially have influenced our results. Occult 
cancer could be a potential confounder in this study. However, sensitivity analysis excluding patients 
who developed cancer in the following year after VTE produced essentially similar results, indicating 
a low probability of confounding by occult cancer.  
In conclusion, hospitalization is a major trigger factor for VTE also in the absence of 
immobilization. However, immobilization contributes substantially to the risk of VTE among 
hospitalized patients. Furthermore, the hospital-associated risk of VTE is mainly dependent on the 
length of hospital stay rather than the frequency of admissions. Our findings highlight that 
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Table 1 Characteristics of venous thromboembolism (VTE) patients (n=530) 





Sex (% women) 
Obesity (% Obese) 
Deep Vein Thrombosis (%) 
Pulmonary Embolism (%) 
Location at VTE onset  
Community 84.0 (445) 
Hospital 10.6 (56) 
Nursing home  5.4 (29) 
Values are means ± 1 SD or percentages with numbers in brackets.  
 
Table 2 Characteristics of hospitalizations in case and control periods 




Infection 15.8 % 13.4 % 
COPD* 4.4 % 2.5 % 
Heart failure 0.6 % 4.0 % 
Acute coronary syndrome 9.5 % 6.0 % 
Neurologic disease 9.5 % 8.5 % 
Surgery or trauma 32.9 % 34.3 % 
Others  27.2 % 31.3 % 
Values are percentages with numbers in brackets.  










Table 3 Odds ratios (ORs) of exposure in hazard period as compared to control periods 





OR (95% CI) ORⱡ (95% CI) 
Hospitalized (n) 132 159 9.4 (6.8-12.8)  
Length of hospital stay (IQR) * 6 (3-12) 11 (6-18) 1.11 (1.04-1.18)  
Hospital stay ≥ 5 days† 75 134 5.2 (1.8-15.1)  
Number of hospitalizations     
0 1988 371 Ref.  
1 109 130 8.9 (6.4-12.4) Ref. 
≥2 23 29 12.3 (6.4-23.6) 1.8 (0.6-5.2) 
*Median (interquartile range, IQR)  
†Compared to patients hospitalized for 1-4 days.  
ⱡAdjusted for the length of hospital stay  
 
 
Table 4 Odds ratios (ORs) of VTE according to hospitalization with and without immobilization. 
 Control periods Hazard period All Restricted to non-surgical* 
 (n=2120) (n=530) OR (95% CI) OR (95% CI) 
Not hospitalized 1988 374 Ref. Ref. 
Hospitalized without immobilization 98 85 6.3 (4.4-9.2) 5.0 (3.2-7.9) 
Hospitalized with immobilization 34 74 19.8 (11.5-34.0) 14.4 (7.4-27.9) 




Legends to figures  
Figure 1 The Case-crossover study design 
 
 
 
